Rogier Goetgebuer

Predicting response to iron supplementation in patients with active inflammatory bowel disease (PRIme): a randomised trial protocol

Loveikyte, R., Duijvestein, M., Mujagic, Z., Goetgebuer, R. L., Dijkstra, G. & van der Meulen-de Jong, A. E., 30 Jan 2024, In: BMJ Open. 14, 1, e077511.

Research output: Contribution to journal › Article › Academic › peer-review

Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory Diseases

Cheung, M. W., Dayam, R. M., Shapiro, J. R., Law, J. C., Chao, G. Y. C., Pereira, D., Goetgebuer, R. L., Croitoru, D., Stempak, J. M., Acheampong, L., Rizwan, S., Lee, J. D., Jacob, L., Ganatra, D., Law, R., Rodriguez-Castellanos, V. E., Kern-Smith, M., Delgado-Brand, M., Mailhot, G., Haroon, N., & 6 othersInman, R. D., Piguet, V., Chandran, V., Silverberg, M. S., Watts, T. H. & Gingras, A-C., 1 Aug 2023, In: Journal of immunology (Baltimore, Md.. 211, 3, p. 351-364 14 p.

Research output: Contribution to journal › Article › Academic › peer-review

Cumulative exposure to immunomodulators increases risk of cervical neoplasia in women with inflammatory bowel disease

the Dutch Initiative on Crohn and Colitis (ICC), 1 Jul 2023, In: Alimentary Pharmacology and Therapeutics. 58, 2, p. 207-217 11 p.

Research output: Contribution to journal › Article › Academic › peer-review